Wiegand F

Beckley Psytech Ltd, Oxford, UK.

1 paper

Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy-<i>N,N</i>-dimethyltryptamine benzoate) in healthy participants.

Rucker JJ, Roberts C, Seynaeve M +6